Correlation Between Pfizer and 345397XL2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and FORD MTR CR, you can compare the effects of market volatilities on Pfizer and 345397XL2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 345397XL2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 345397XL2.
Diversification Opportunities for Pfizer and 345397XL2
Very weak diversification
The 3 months correlation between Pfizer and 345397XL2 is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and FORD MTR CR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FORD MTR CR and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 345397XL2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FORD MTR CR has no effect on the direction of Pfizer i.e., Pfizer and 345397XL2 go up and down completely randomly.
Pair Corralation between Pfizer and 345397XL2
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 345397XL2. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 45.88 times less risky than 345397XL2. The stock trades about -0.07 of its potential returns per unit of risk. The FORD MTR CR is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 9,473 in FORD MTR CR on September 2, 2024 and sell it today you would earn a total of 297.00 from holding FORD MTR CR or generate 3.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 91.13% |
| Values | Daily Returns |
Pfizer Inc vs. FORD MTR CR
Performance |
| Timeline |
| Pfizer Inc |
| FORD MTR CR |
Pfizer and 345397XL2 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 345397XL2
The main advantage of trading using opposite Pfizer and 345397XL2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 345397XL2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 345397XL2 will offset losses from the drop in 345397XL2's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| 345397XL2 vs. AEP TEX INC | 345397XL2 vs. US BANK NATIONAL | 345397XL2 vs. American Express | 345397XL2 vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |